Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.

About this item

Title

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.

Content partner

The University of Auckland Library

Collection

ResearchSpace@Auckland

Description

BackgroundFebrile neutropenia (FN) is a prevalent and potentially life-threatening complication in patients with lymphoma receiving myelosuppressive chemotherapy. Pegfilgrastim is more effective than filgrastim as prophylaxis for FN. However, its usage has been limited because of its higher cost. Pegfilgrastim's value for money remains unclear.ObjectiveTo systematically review the cost-effectiveness of pegfilgrastim compared to filgrastim as a primary or secondary prophylaxis for chemotherapy...

Read more

Format

Research paper

Research format

Journal article

Date created

2022-12

Creator

Gebremariam, Girma Tekle / Fentie, Atalay Mulu / Beyene, Kebede / Sander, Beate / Gebretekle, Gebremedhin Beedemariam

URL

https://hdl.handle.net/2292/63238

Related subjects

Humans / Lymphoma / Polyethylene Glycols / Filgrastim / Granulocyte Colony-Stimulating Factor / Recombinant Proteins / Antineoplastic Agents / Antineoplastic Combined Chemotherapy Protocols / Cost-Benefit Analysis / Febrile Neutropenia / Chemotherapy-Induced Febrile Neutropenia / Cost-effectiveness / Pegfilgrastim / Prophylaxis / Health Services / Comparative Effectiveness Research / Cancer / Clinical Research / Prevention / Rare Diseases / Hematology / Cost Effectiveness Research / 3 Good Health and Well Being / 0807 Library and Information Studies / 1110 Nursing / 1117 Public Health and Health Services

What is the copyright status of this item?

Share

See below for specifics about how you may use this item.

More Information

The University of Auckland Library has this to say about the rights status of this item:

Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.

You can learn more about the rights status of this item at:

• https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
• http://purl.org/eprint/accessRights/OpenAccess

What can I do with this item?

You must always check with The University of Auckland Library to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

Share it

This item is suitable for copying and sharing with others, without further permission.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.